Stay updated on GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page.

Latest updates to the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page
- ChecktodayChange DetectedDifference0.9%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference1%
- Check15 days agoChange DetectedDifference0.8%
- Check22 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed descriptions of a clinical trial for GD2-SADA:177Lu-DOTA complex, which included specific patient criteria and treatment phases, while adding a new revision number and a brief mention of SCLC and other cancers.SummaryDifference24%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.9%
- Check44 days agoChange DetectedDifference0.6%
Stay in the know with updates to GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page.